Tuberculosis Diagnostics Market Driving Growth in United States | Exhibit 4.9% CAGR by 2028
The
global tuberculosis diagnostics market size was valued at USD 1.96 billion in 2020. The market valuation is predicted to
increase from USD 2.05 billion in 2021
to USD 2.87 billion in 2028 at a CAGR of 4.9% during the projected
timeline. The market is driven by the need for improved diagnostics solutions
in order to address the increasing burden of tuberculosis. Continuous advances
in TB diagnostics will transform the market outlook in the forthcoming years,
states Fortune Business Insights
in its report titled “Tuberculosis
(TB) Diagnostics Market, 2021-2028."
Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/tuberculosis-tb-diagnostics-market-102009
Tuberculosis
(TB) is a highly contagious pulmonary disorder caused by Mycobacterium
tuberculosis – a type of bacteria that typically attacks the patient’s lungs.
The infection can also other body parts such as the brain and spine. TB blood
test and TB skin test are commonly used methods for the detection of this
bacteria in the body. A significant occurrence of the disease worldwide has
created the need for improved diagnostic technologies. Active healthcare
investments to address the rising burden of the disease will fuel the market
size during 2021-2028.
Regional
Insights:
North America generated USD 0.56 billion in
the worldwide tuberculosis (TB) diagnostics market share in 2020 and will grow
substantially through 2028. The regional growth is attributable to the
economically stable and highly aware population. An established healthcare
system and widespread adoption of technologically advanced products will benefit
the regional outlook.
Europe is slated to witness notable growth in
the market led by rising R&D in the field of tuberculosis diagnostics.
Meanwhile, the market in Asia Pacific will gain traction led by the widespread
occurrence of TB and a vast geriatric population base.
The
Report Lists the Key Players Profiled in the Market Report:
·
F. Hoffmann-La
Roche Ltd (Basel, Switzerland)
·
bioMérieux SA
(Marcy l'Etoile, France)
·
QIAGEN (Venlo,
Netherlands)
·
BD (Becton,
Dickinson and Company) (New Jersey, U.S.)
·
Danaher
(Washington D.C., U.S.)
·
Thermo Fisher
Scientific Inc. (Waltham, U.S.)
·
Abbott (Illinois,
U.S.)
·
Hologic Inc.
(Marlborough, U.S.)
·
Hain Lifescience
GmbH (Nehren, Germany)
·
Oxford Immunotec
(Abingdon, U.K.)
About Us:
Fortune
Business Insights™ offers expert corporate analysis and accurate data, helping
organizations of all sizes make timely decisions. We tailor innovative
solutions for our clients, assisting them to address challenges distinct to
their businesses. Our goal is to empower our clients with holistic market
intelligence, giving a granular overview of the market they are operating in.
Our
reports contain a unique mix of tangible insights and qualitative analysis to
help companies achieve sustainable growth. Our team of experienced analysts and
consultants use industry-leading research tools and techniques to compile
comprehensive market studies, interspersed with relevant data.
At
Fortune Business Insights™, we aim at highlighting the most lucrative growth
opportunities for our clients. We, therefore, offer recommendations, making it
easier for them to navigate through technological and market-related changes.
Our consulting services are designed to help organizations identify hidden
opportunities and understand prevailing competitive challenges.
Comments
Post a Comment